id: P41226
gene_symbol: UBA7
aliases:
  - UBE1L
  - UBE2
  - D8
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: UBA7 (Ubiquitin-like modifier-activating enzyme 7) is the sole E1 activating enzyme for ISG15 (interferon-stimulated gene 15), catalyzing the ATP-dependent activation of ISG15 and its transfer to the E2 enzyme UBE2L6. As the initiating enzyme of the ISGylation pathway, UBA7 plays a critical role in innate antiviral immunity and cellular stress responses. The protein is localized to both cytoplasm and nucleus, where it modifies diverse substrates including antiviral effectors and tumor suppressors like p53. UBA7 functions as a tumor suppressor that is frequently downregulated in cancers, and its loss increases susceptibility to viral infections.
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UBA7 localizes to the cytoplasm where it activates ISG15 and modifies cytoplasmic substrates. This localization is supported by extensive experimental evidence including immunofluorescence studies (PMID:29743376) and is essential for ISGylation of cytoplasmic antiviral proteins.
    action: ACCEPT
    reason: Core cellular component annotation with strong experimental support. UBA7 is indeed present in the cytoplasm where it performs ISG15 activation and modifies cytoplasmic proteins involved in antiviral defense.
    supported_by:
      - reference_id: PMID:29743376
        supporting_text: "Consistently, colocalization of pUL50 with UBE1L was observed in cells treated with a proteasome inhibitor."
- term:
    id: GO:0019782
    label: ISG15 activating enzyme activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UBA7 is the sole E1 enzyme for ISG15, catalyzing ATP-dependent ISG15 activation and thioester bond formation. This is the primary molecular function of UBA7, extensively validated through biochemical and genetic studies showing it specifically activates ISG15 but not ubiquitin in mammals.
    action: ACCEPT
    reason: This is the core molecular function of UBA7. Multiple studies demonstrate UBA7 (UBE1L) specifically activates ISG15 and transfers it to UBE2L6. Knockout mice lacking UBA7 cannot perform ISGylation and are highly susceptible to viral infections.
    supported_by:
      - reference_id: PMID:16428300
        supporting_text: "UBE1L and UbcH8 have been reported to function as E1 and E2 enzymes, respectively, for ISG15 conjugation."
      - reference_id: PMID:19073728
        supporting_text: "the importance of UbE1L was confirmed by demonstrating that mice lacking this ISG15 E1 enzyme were highly susceptible to Sindbis virus infection."
- term:
    id: GO:0032020
    label: ISG15-protein conjugation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UBA7 initiates ISG15-protein conjugation (ISGylation) by activating ISG15 and transferring it to UBE2L6. This is the primary biological process mediated by UBA7, essential for antiviral immunity and protein regulation.
    action: ACCEPT
    reason: Core biological process annotation. UBA7 is absolutely required for ISGylation - it is the sole E1 enzyme that initiates the ISG15 conjugation cascade. This function is well-established through multiple experimental approaches.
    supported_by:
      - reference_id: PMID:16428300
        supporting_text: "ISG15 is considered to be covalently conjugated to cellular proteins through a sequential reaction similar to that of the ubiquitin conjugation system consisting of E1/E2/E3 enzymes: UBE1L and UbcH8 have been reported to function as E1 and E2 enzymes, respectively, for ISG15 conjugation."
- term:
    id: GO:0045087
    label: innate immune response
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UBA7-mediated ISGylation is a critical component of the innate immune response, particularly antiviral defense. UBA7 knockout mice are highly susceptible to viral infections, demonstrating its essential role in innate immunity.
    action: ACCEPT
    reason: Well-established role in innate immunity. UBA7 is an interferon-stimulated gene that enables ISGylation of antiviral proteins. Genetic ablation studies confirm its requirement for innate immune control of multiple viruses.
    supported_by:
      - reference_id: PMID:19073728
        supporting_text: "ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus."
- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UBA7 participates in the DNA damage response through ISGylation of p53 and other DNA damage response factors. DNA damage induces UBA7 expression and subsequent ISGylation enhances p53 transactivation activity.
    action: ACCEPT
    reason: Valid annotation supported by literature. UBA7-mediated ISGylation of p53 occurs in response to DNA damage and modulates p53 activity, contributing to the cellular DNA damage response.
    additional_reference_ids:
      - PMID:27545325
- term:
    id: GO:0008641
    label: ubiquitin-like modifier activating enzyme activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: UBA7 is indeed a ubiquitin-like modifier activating enzyme, but this general term is less informative than the specific ISG15 activating enzyme activity (GO:0019782). UBA7 specifically activates ISG15, not other ubiquitin-like modifiers in mammals.
    action: MODIFY
    reason: While technically correct, this annotation is too general. UBA7 specifically activates ISG15, not other ubiquitin-like modifiers. The more specific term GO:0019782 (ISG15 activating enzyme activity) better captures UBA7's molecular function.
    proposed_replacement_terms:
      - id: GO:0019782
        label: ISG15 activating enzyme activity
- term:
    id: GO:0000166
    label: nucleotide binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: UBA7 binds ATP for ISG15 adenylation, but this general nucleotide binding term is less informative than the specific ATP binding activity (GO:0005524) that is mechanistically required for ISG15 activation.
    action: MODIFY
    reason: While UBA7 does bind nucleotides, specifically ATP is required for its enzymatic function. The more specific GO:0005524 (ATP binding) annotation is already present and more informative.
    proposed_replacement_terms:
      - id: GO:0005524
        label: ATP binding
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: UBA7 requires ATP binding for ISG15 activation. The adenylation domain binds ATP to catalyze formation of the ISG15-adenylate intermediate, an essential step in the ISGylation cascade.
    action: ACCEPT
    reason: Core molecular function. ATP binding is mechanistically required for UBA7's E1 enzyme activity - it uses ATP to adenylate ISG15's C-terminus before thioester bond formation. This is well-documented in structural and biochemical studies.
    supported_by:
      - reference_id: PMID:16428300
        supporting_text: "ISG15 is considered to be covalently conjugated to cellular proteins through a sequential reaction similar to that of the ubiquitin conjugation system consisting of E1/E2/E3 enzymes"
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: UBA7 localizes to the nucleus/nucleoplasm where it can ISGylate nuclear proteins including p53 and other transcription factors. Both immunocytochemistry and functional studies support nuclear localization.
    action: ACCEPT
    reason: Valid cellular component annotation. UBA7 is present in the nucleus where it modifies nuclear substrates like p53. The nuclear localization is experimentally validated and functionally relevant for ISGylation of nuclear proteins.
    supported_by:
      - reference_id: PMID:29743376
        supporting_text: "pUL50 interacted with UBE1L, an E1-activating enzyme for ISGylation"
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This is a duplicate annotation - GO:0005737 (cytoplasm) with IBA evidence is already present and accepted. This IEA annotation is redundant.
    action: REMOVE
    reason: Redundant annotation. The same cellular component (cytoplasm) is already annotated with stronger IBA evidence code. No need for duplicate weaker IEA annotation.
- term:
    id: GO:0016874
    label: ligase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: UBA7 has ligase activity as an E1 enzyme that catalyzes thioester bond formation with ISG15. However, the more specific term GO:0019782 (ISG15 activating enzyme activity) better describes its function.
    action: MODIFY
    reason: While UBA7 does have ligase activity (forms thioester bonds), this term is too general. The specific ISG15 activating enzyme activity (GO:0019782) more accurately describes UBA7's molecular function.
    proposed_replacement_terms:
      - id: GO:0019782
        label: ISG15 activating enzyme activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:16189514
  review:
    summary: Generic protein binding annotation from a large-scale interactome study. While UBA7 does interact with proteins (ISG15, UBE2L6), this uninformative term doesn't specify which proteins or the functional significance.
    action: REMOVE
    reason: Protein binding is too generic and uninformative. UBA7 obviously binds proteins as part of its enzymatic function (ISG15, UBE2L6), but this annotation provides no useful functional information. The specific enzymatic activities are already captured in other annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:17597759
  review:
    summary: Another generic protein binding annotation. The referenced paper studies E1-E2 interactions, but the generic protein binding term doesn't capture the specific functional interactions.
    action: REMOVE
    reason: Too generic and uninformative. While the paper studies E1-E2 charging mechanisms, the generic protein binding term adds no functional information beyond what's captured in the ISG15 activating enzyme activity annotation.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25416956
  review:
    summary: Generic protein binding from another interactome study. Provides no specific functional information about UBA7's enzymatic activities or biological roles.
    action: REMOVE
    reason: Uninformative generic annotation. The specific protein interactions relevant to UBA7 function (with ISG15, UBE2L6) are better captured by the enzymatic activity annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: Generic protein binding from a reference interactome map. No specific functional information provided.
    action: REMOVE
    reason: Generic and uninformative. UBA7's specific protein interactions that matter functionally are already captured in its enzymatic activity annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Generic protein binding from a neurodegenerative disease interactome study. No specific functional relevance to UBA7's core activities.
    action: REMOVE
    reason: Generic and uninformative annotation. The specific functionally relevant protein interactions for UBA7 are already captured in its enzymatic activity annotations.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: Generic protein binding from a cell-specific interactome study. Provides no specific functional information about UBA7.
    action: REMOVE
    reason: Uninformative generic annotation that doesn't specify which proteins or functional significance. UBA7's specific enzymatic interactions are already captured.
- term:
    id: GO:0019782
    label: ISG15 activating enzyme activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate annotation - GO:0019782 with IBA evidence is already present and accepted. This IEA annotation is redundant.
    action: REMOVE
    reason: Redundant annotation. The same molecular function (ISG15 activating enzyme activity) is already annotated with stronger IBA evidence. No need for duplicate weaker IEA annotation.
- term:
    id: GO:0019941
    label: modification-dependent protein catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: UBA7-mediated ISGylation can lead to degradation of certain proteins (e.g., PML-RARÎ±, cyclin D1), but this is an indirect downstream effect rather than UBA7's primary function.
    action: KEEP_AS_NON_CORE
    reason: Valid but non-core function. While ISGylation by UBA7 can target some proteins for degradation, this is a downstream consequence rather than the primary function. The core function is ISG15 activation and conjugation.
- term:
    id: GO:0032020
    label: ISG15-protein conjugation
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: Duplicate annotation - GO:0032020 with IBA evidence is already present and accepted. This IEA annotation is redundant.
    action: REMOVE
    reason: Redundant annotation. The same biological process (ISG15-protein conjugation) is already annotated with stronger IBA evidence. No need for duplicate weaker IEA annotation.
- term:
    id: GO:0004842
    label: ubiquitin-protein transferase activity
  evidence_type: EXP
  original_reference_id: PMID:18583345
  review:
    summary: This annotation is incorrect. UBA7 is an E1 activating enzyme, not an E2/E3 transferase. The paper actually studies E1-E2 interactions in ISGylation, not ubiquitin transfer. UBA7 activates ISG15, not ubiquitin.
    action: MODIFY
    reason: Incorrect annotation. UBA7 is an E1 enzyme that activates ISG15, not an E2/E3 transferase. The term ubiquitin-protein transferase activity refers to E2/E3 enzymes. UBA7 should be annotated with ISG15 activating enzyme activity instead.
    proposed_replacement_terms:
      - id: GO:0019782
        label: ISG15 activating enzyme activity
    additional_reference_ids:
      - PMID:18583345
- term:
    id: GO:0004842
    label: ubiquitin-protein transferase activity
  evidence_type: EXP
  original_reference_id: PMID:19073728
  review:
    summary: Incorrect annotation. The paper clearly identifies UBA7 (UbE1L) as the E1 enzyme for ISG15, not a transferase. UBA7 activates ISG15, it doesn't transfer ubiquitin.
    action: MODIFY
    reason: Misannotation. The cited paper explicitly states UBA7/UbE1L is the ISG15 E1 activating enzyme, not an E2/E3 transferase. It should be annotated with ISG15 activating enzyme activity.
    proposed_replacement_terms:
      - id: GO:0019782
        label: ISG15 activating enzyme activity
    supported_by:
      - reference_id: PMID:19073728
        supporting_text: "the importance of UbE1L was confirmed by demonstrating that mice lacking this ISG15 E1 enzyme were highly susceptible to Sindbis virus infection"
- term:
    id: GO:0016567
    label: protein ubiquitination
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  review:
    summary: Incorrect process annotation. UBA7 mediates ISGylation (ISG15 conjugation), not ubiquitination. UBA7 is highly specific for ISG15 in mammals and does not activate ubiquitin.
    action: MODIFY
    reason: Wrong process. UBA7 specifically mediates ISG15-protein conjugation (ISGylation), not protein ubiquitination. In mammals, UBA7 cannot activate ubiquitin, only ISG15.
    proposed_replacement_terms:
      - id: GO:0032020
        label: ISG15-protein conjugation
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:29743376
  review:
    summary: Direct experimental evidence for cytoplasmic localization of UBA7 (UBE1L) through immunofluorescence and colocalization studies in the context of HCMV infection.
    action: ACCEPT
    reason: Strong experimental evidence for cytoplasmic localization. The paper demonstrates UBA7/UBE1L localization and its functional relevance in the cytoplasm.
    supported_by:
      - reference_id: PMID:29743376
        supporting_text: "colocalization of pUL50 with UBE1L was observed in cells treated with a proteasome inhibitor"
- term:
    id: GO:0032020
    label: ISG15-protein conjugation
  evidence_type: IDA
  original_reference_id: PMID:15131269
  review:
    summary: Direct experimental evidence that UBA7 (UBE1L) mediates ISG15-protein conjugation, working with UbcH8 as the E2 enzyme in the ISGylation cascade.
    action: ACCEPT
    reason: Strong experimental evidence for UBA7's role in ISG15-protein conjugation. The paper directly demonstrates the E1-E2 cascade for ISGylation.
    supported_by:
      - reference_id: PMID:15131269
        supporting_text: "The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein"
- term:
    id: GO:0032020
    label: ISG15-protein conjugation
  evidence_type: IDA
  original_reference_id: PMID:16407192
  review:
    summary: Experimental evidence showing UBA7 participates in ISG15-protein conjugation, working with HERC5 as the E3 ligase in the ISGylation pathway.
    action: ACCEPT
    reason: Direct experimental evidence for ISGylation. The paper demonstrates the complete ISGylation cascade including UBA7's role as the E1 enzyme.
    supported_by:
      - reference_id: PMID:16407192
        supporting_text: "Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells"
- term:
    id: GO:0045087
    label: innate immune response
  evidence_type: IDA
  original_reference_id: PMID:28724761
  review:
    summary: Direct experimental evidence that UBA7-mediated ISGylation modulates type I interferon signaling and antiviral response during hepatitis E virus replication.
    action: ACCEPT
    reason: Strong experimental evidence for role in innate immunity. The paper directly demonstrates ISGylation's role in antiviral defense and interferon signaling.
    supported_by:
      - reference_id: PMID:28724761
        supporting_text: "ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication"
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5653754
  review:
    summary: Curated annotation from Reactome showing UBA7 localizes to nucleoplasm where it can ISGylate nuclear proteins including monoubiquitinated PCNA.
    action: ACCEPT
    reason: Valid cellular component annotation from curated Reactome pathway. UBA7 is present in the nucleoplasm where it modifies nuclear proteins. This is consistent with experimental evidence of nuclear localization.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1169397
  review:
    summary: Curated annotation from Reactome pathway 'Activation of ISG15 by UBA7 E1 ligase' showing cytosolic localization where ISG15 activation occurs.
    action: ACCEPT
    reason: Valid cellular component annotation from curated Reactome pathway. UBA7 functions in the cytosol to activate ISG15. Multiple Reactome pathways consistently place UBA7 in the cytosol.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1169404
  review:
    summary: Curated annotation from Reactome pathway 'Transfer of ISG15 from E1 to E2 (UBCH8)' confirming cytosolic localization.
    action: ACCEPT
    reason: Valid annotation from curated pathway. Shows UBA7 in cytosol transferring ISG15 to the E2 enzyme UBE2L6/UBCH8.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-936563
  review:
    summary: Curated annotation from Reactome pathway 'ISGylation of DDX58' showing cytosolic localization for ISGylation of RIG-I.
    action: ACCEPT
    reason: Valid annotation showing UBA7 in cytosol for ISGylation of the antiviral sensor RIG-I/DDX58.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9927247
  review:
    summary: Another Reactome annotation for ISGylation of DDX58 (RIG-I) in cytosol. Multiple consistent cytosolic annotations from curated pathways.
    action: ACCEPT
    reason: Consistent with other curated annotations placing UBA7 in cytosol for ISGylation reactions.
    supported_by:
      - reference_id: Reactome:R-HSA-9927247
        supporting_text: "ISGylation requires a three-step process, involving an E1 activating enzyme (UBE1L), an E2 conjugating enzyme (UbcM8/H8), and HERC5/Ceb1 an IFN-inducible ISG15-specific E3 ligase"
- term:
    id: GO:0019782
    label: ISG15 activating enzyme activity
  evidence_type: IDA
  original_reference_id: PMID:16428300
  review:
    summary: Direct experimental demonstration that UBA7 (UBE1L) functions as the E1 activating enzyme for ISG15, forming thioester intermediates and transferring ISG15 to UbcH8.
    action: ACCEPT
    reason: Strong direct experimental evidence for ISG15 activating enzyme activity. The paper demonstrates UBA7/UBE1L activates ISG15 and transfers it to the E2 enzyme.
    supported_by:
      - reference_id: PMID:16428300
        supporting_text: "UBE1L and UbcH8 have been reported to function as E1 and E2 enzymes, respectively, for ISG15 conjugation"
- term:
    id: GO:0032020
    label: ISG15-protein conjugation
  evidence_type: IDA
  original_reference_id: PMID:16428300
  review:
    summary: Direct experimental evidence that UBA7 mediates ISG15-protein conjugation, specifically showing ISG15 conjugation to UbcH6 and other substrates.
    action: ACCEPT
    reason: Strong experimental evidence for ISGylation. The paper directly demonstrates UBA7's essential role in ISG15-protein conjugation.
    supported_by:
      - reference_id: PMID:16428300
        supporting_text: "ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme"
- term:
    id: GO:0034341
    label: response to type II interferon
  evidence_type: ISS
  original_reference_id: PMID:31974171
  review:
    summary: UBA7 is an interferon-stimulated gene that is robustly induced by interferons as part of the antiviral response program.
    action: NEW
    reason: Direct regulation by interferons is a key aspect of UBA7 function not captured in existing annotations. Upon IFN treatment, UBA7 levels rise alongside ISG15.
    supported_by:
      - reference_id: PMID:31974171
        supporting_text: "Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing"
- term:
    id: GO:0032480
    label: negative regulation of type I interferon production
  evidence_type: ISS
  original_reference_id: PMID:28724761
  review:
    summary: ISGylation mediated by UBA7 can regulate interferon signaling in a negative feedback manner through modification of signaling proteins.
    action: NEW
    reason: UBA7-mediated ISGylation modulates interferon signaling pathways, creating regulatory feedback loops in immune responses.
    supported_by:
      - reference_id: PMID:28724761
        supporting_text: "ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication"
core_functions:
  - description: Catalyzes ATP-dependent activation of ISG15 through adenylation and thioester bond formation with Cys599, then transfers activated ISG15 to E2 enzyme UBE2L6
    molecular_function:
      id: GO:0019782
      label: ISG15 activating enzyme activity
    directly_involved_in:
      - id: GO:0032020
        label: ISG15-protein conjugation
      - id: GO:0045087
        label: innate immune response
      - id: GO:0006974
        label: DNA damage response
    locations:
      - id: GO:0005829
        label: cytosol
      - id: GO:0005654
        label: nucleoplasm
    substrates:
      - id: UniProtKB:P05161
        label: ISG15
  - description: Initiates antiviral ISGylation cascade that restricts viral replication by modifying host and viral proteins
    molecular_function:
      id: GO:0019782
      label: ISG15 activating enzyme activity
    directly_involved_in:
      - id: GO:0045087
        label: innate immune response
      - id: GO:0051607
        label: defense response to virus
    locations:
      - id: GO:0005829
        label: cytosol
    supported_by:
      - reference_id: PMID:19073728
        supporting_text: "mice lacking this ISG15 E1 enzyme were highly susceptible to Sindbis virus infection"
      - reference_id: PMID:28724761
        supporting_text: "ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication"
  - description: Promotes tumor suppression through ISGylation-mediated degradation of oncogenic proteins
    molecular_function:
      id: GO:0019782
      label: ISG15 activating enzyme activity
    directly_involved_in:
      - id: GO:0019941
        label: modification-dependent protein catabolic process
      - id: GO:0008285
        label: negative regulation of cell population proliferation
    locations:
      - id: GO:0005829
        label: cytosol
      - id: GO:0005654
        label: nucleoplasm
    substrates:
      - id: UniProtKB:P29590
        label: PML
      - id: UniProtKB:P24385
        label: cyclin D1
    supported_by:
      - reference_id: PMID:27545325
        supporting_text: "UBA7 frequently downregulated in lung and breast cancers and functions as tumor suppressor"
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping.
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:15131269
  title: The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced
    ubiquitin-like protein.
  findings: []
- id: PMID:16189514
  title: Towards a proteome-scale map of the human protein-protein interaction network.
  findings: []
- id: PMID:16407192
  title: Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation
    of ISG15 in human cells.
  findings: []
- id: PMID:16428300
  title: 'Link between the ubiquitin conjugation system and the ISG15 conjugation
    system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme.'
  findings: []
- id: PMID:17597759
  title: Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme
    charging.
  findings: []
- id: PMID:18583345
  title: The basis for selective E1-E2 interactions in the ISG15 conjugation system.
  findings: []
- id: PMID:19073728
  title: ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate
    immune control of Sindbis virus.
  findings: []
- id: PMID:25416956
  title: A proteome-scale map of the human interactome network.
  findings: []
- id: PMID:28724761
  title: ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during
    Hepatitis E Virus Replication.
  findings: []
- id: PMID:29743376
  title: Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation
    by Downregulating UBE1L.
  findings: []
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
- id: PMID:32814053
  title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
    and Uncovers Widespread Protein Aggregation in Affected Brains.
  findings: []
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
- id: Reactome:R-HSA-1169397
  title: Activation of ISG15 by UBA7 E1 ligase
  findings: []
- id: Reactome:R-HSA-1169404
  title: Transfer of ISG15 from E1 to E2 (UBCH8)
  findings: []
- id: Reactome:R-HSA-5653754
  title: UBE2L6:TRIM25 ISGylates monoUb:K164-PCNA
  findings: []
- id: Reactome:R-HSA-936563
  title: ISGylation of DDX58
  findings: []
- id: Reactome:R-HSA-9927247
  title: ISGylation of DDX58 (RIG-I)
  findings: []
- id: PMID:27545325
  title: 'Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.'
  findings: []
- id: PMID:31974171
  title: 'Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing.'
  findings: []

suggested_questions:
- question: How does UBA7 specifically activate ISG15 and what determines its selectivity for this ubiquitin-like modifier?
- question: What role does UBA7 play in antiviral immunity and how is its activity regulated during viral infections?
- question: How do different ISG15 conjugates formed by UBA7 contribute to interferon-mediated cellular responses?
- question: What are the structural determinants that allow UBA7 to function as an E1 enzyme for ISG15 but not ubiquitin?
suggested_experiments:
- description: Structural biology approaches to determine the molecular basis of UBA7-ISG15 interaction and activation mechanisms
- description: Proteomics analysis to identify the complete landscape of ISG15 conjugation targets downstream of UBA7
- description: Live-cell imaging to study UBA7 dynamics and ISG15 conjugation during viral infection and interferon responses
- description: Biochemical reconstitution of the ISG15 conjugation pathway to study UBA7 enzyme kinetics and regulation
